The future of HIV prevention in the United States

JAMA. 2012 Jul 25;308(4):347-8. doi: 10.1001/jama.2012.8693.
No abstract available

MeSH terms

  • Anti-Retroviral Agents / administration & dosage*
  • Centers for Disease Control and Prevention, U.S.
  • Cost-Benefit Analysis
  • Female
  • Financing, Government
  • Goals
  • HIV Infections / epidemiology*
  • HIV Infections / prevention & control*
  • HIV Infections / transmission
  • Health Policy
  • Humans
  • Incidence
  • Male
  • Policy Making
  • Public Health
  • Randomized Controlled Trials as Topic
  • Research Support as Topic
  • Risk-Taking
  • United States / epidemiology

Substances

  • Anti-Retroviral Agents